JD HEALTH INTL LTD (8ZN) — Cash Flow Reinvestment Rate

Latest as of June 2023: 19.73x

JD HEALTH INTL LTD (8ZN) has a Cash Flow Reinvestment Rate of 19.73x as of June 2023, reinvesting €3.63 Billion (capex €19.75 Million plus investments €-3.61 Billion) from operating cash flow of €184.04 Million. Explore 8ZN capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

19.73x
(Capex + Investments) / Operating CF

Total Reinvested

€3.63 Billion
Capex + Investments

Operating Cash Flow

€184.04 Million
EUR

Capital Expenditures

€19.75 Million
EUR

JD HEALTH INTL LTD Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for JD HEALTH INTL LTD across 7 annual periods. Also explore JD HEALTH INTL LTD (8ZN) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for JD HEALTH INTL LTD (2019–2025)

Year-by-year capital reinvestment analysis for JD HEALTH INTL LTD. For live market cap and broader valuation context, see 8ZN stock market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.06x €615.57 Million €10.17 Billion €151.01 Million ▼ -92.0%
2024 0.75x €3.26 Billion €4.33 Billion €46.35 Million ▼ -56.9%
2023 1.75x €8.04 Billion €4.60 Billion €69.33 Million ▲ +416.2%
2022 0.34x €2.00 Billion €5.91 Billion €40.16 Million ▼ -93.5%
2021 5.17x €17.75 Billion €3.43 Billion €502.21 Million ▲ +152.7%
2020 2.05x €7.57 Billion €3.70 Billion €15.70 Million ▼ -42.0%
2019 3.53x €1.45 Billion €409.47 Million €5.19 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow